Endogena Therapeutics Secures FDA Green Light for Breakthrough AMD Treatment
SAN FRANCISCO and TORONTO and ZURICH, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a pioneering biotech company dedicated to revolutionizing regenerative medicine, is proud to announce a significant achievement that holds the promise of transforming lives. The U.S. Food and Drug Administration (FDA) has granted clearance for Endogena's Investigational New Drug (IND) application, opening the door to a groundbreaking clinical investigation of EA 2351. This innova...
San Francisco United States Matthias Steger Free Range Communications Drug Administration Endogena Therapeutics Inc
Source: yahoo.com